ITH Pharma specialises in the provision of of aseptic compounding services for all therapy areas - particularly Parenteral Nutrition, Chemotherapy and CIVAS.
The company was launched in October 2008 by the founding members of Intra-Tech Healthcare, so although we're new, we are experienced and have the understanding of what you require from a supplier.
Our team leads the industry in innovation, providing flexible, cost effective services with both batch and bespoke items for adults, paediatrics and neonates.
Revenue (FY, 2017)
Gross profit (FY, 2017)
Gross profit margin (FY, 2017), %
Net income (FY, 2017)
EBITDA (FY, 2017)
EBIT (FY, 2017)
|GBP||FY, 2011||FY, 2012||FY, 2013||FY, 2014||FY, 2015||FY, 2016||FY, 2017|
|34.1 k||335 k||547.1 k||947.3 k||282.2 k||494.6 k||1.7 m|
Cash From Operating Activities
|(198.5 k)||412.8 k||148.6 k||605.7 k||799.8 k||276.4 k||(489.4 k)|
Cash From Financing Activities
|262.9 k||(160.2 k)||(305.9 k)||(1.1 m)||29.8 k|
Net Change in Cash
|(118 k)||88.9 k||(101.8 k)||(744.2 k)||447.4 k||(739.7 k)||(1.8 m)|